Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00918814 · ClinicalTrials.gov registry record · Phase 2
Dose Ranging and Dose Frequency of LIPO-102
A Phase 2 study, sponsored by Neothetics.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT00918814 is a Phase 2 study that has completed, run by Neothetics. The registered enrollment target is 54 participants.
The verdict
NCT00918814, a Phase 2 study, has completed, sponsored by Neothetics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
Dose Ranging and Dose Frequency of LIPO-102
Interventions
- DRUG Placebo
- DRUG LIPO-102
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00918814
The ClinicalTrials.gov registry entry for NCT00918814 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neothetics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00918814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00918814 about?
NCT00918814 is a clinical study titled "Dose Ranging and Dose Frequency of LIPO-102". Dose Ranging and Dose Frequency of LIPO-102
What is the current status of trial NCT00918814?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2009-06. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00918814?
The interventions under investigation include: Placebo (DRUG), LIPO-102 (DRUG).
Who is sponsoring clinical trial NCT00918814?
This trial is sponsored by Neothetics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.